Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Jianyu Weng, MD, Xin Du, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, PhD, Liye Zhong, MD, Miaorong She, PhD, Chengxin Deng, Wei Ling, PhD, Xiaoli Zou, Qunhua Li, Wei Lin, Zhixin Huang

Blood (2009) 114 (22): 1147.

https://doi.org/10.1182/blood.V114.22.1147.1147

Published: 2009

Journal Articles

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Jianyu Weng, MD, Meikun Lü, MD, Xin Du, PhD, Lin Xu, PhD, Suxia Geng, MD, Rong Guo, PhD, Suijin Wu, MD, Wei Ling, PhD, Yuchun Wang

Blood (2009) 114 (22): 4499.

https://doi.org/10.1182/blood.V114.22.4499.4499

Published: 2009

Journal Articles

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Jianyu Weng, MD, Xin Du, PhD/MD, Peng Xiang, PhD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Wei Ling, MD

Blood (2008) 112 (11): 4364.

https://doi.org/10.1182/blood.V112.11.4364.4364

Published: 2008

Journal Articles

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

Weng Jianyu, MD, Xin Du, MD, PhD, Xiang Peng, MD, Zhang Xiumin, MD, Suijin Wu, MD, Zesheng Lu, MD, Chengwei Luo, MD, Rong Guo, MD, Chengxin Deng, MD, Wei Ling, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2007) 110 (11): 4968.

https://doi.org/10.1182/blood.V110.11.4968.4968

Published: 2007

Journal Articles

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

Xin Du, MD, PhD, Yangqiu Li, MD, Suxia Geng, MD, Jianyu Weng, MD, Zesheng Lu, MD, Suijin Wu, MD, Chenxin Deng, MD, Wei Ling, MD, Haizhou Xing, MD, Changchun Wan, MD, Chenwei Luo, MD, Liye Zhong, MD, Miaorong She, MD, Xiaoli Zhou, MD, Qunhua Li, MD, Wei Lin, MD, Zilun Huang, MD, Shaohua Chen, MD

Blood (2007) 110 (11): 4970.

https://doi.org/10.1182/blood.V110.11.4970.4970

Published: 2007

Journal Articles

CD4 + CD28 + T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.

Jianyu Weng, MD, Xin Du, Ph.D, Jianjun Zhang, MD, Suijin Wu, MD, Zesheng Lu, MD, Maohua Zhou, MD, Wei Lin, MD, Zilun Huang, MD

Blood (2005) 106 (11): 3922.

https://doi.org/10.1182/blood.V106.11.3922.3922

Published: 2005

NARROW

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

CD4 + CD28 + T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.

Email alerts

ASH Publications

American Society of Hematology

Fludarabine, Cytarabine, Busulphan, and Cyclophosphamide (FABC) as Conditioning Regimen in Hematopoietic Stem Cell Transplantation for Treatment of 92 Patients with Hematologic Malignancies.

Different Dosage of Bortezomib Impacts the Prevention of Acute Graft-Versus-Host Disease.

Mesenchymal Stem Cells Derived from Different Donors as Salvage Therapy for Resistant Severe Acute Graft-Versus-Host Disease

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-Versus-Host Disease.

The Studies on the T-Cell Receptor Repertoire Diversity and Flow Cytometric Analysis in a Patient with MAS/HPS after Unrelated Peripheral Blood Stem Cell Transplantation.

CD4 + CD28 + T Lymphoctye Subsets Decreased in Healthy Donors after G-CSF Mobilization.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only